PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS)

About the company

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiopulmonary diseases. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

40

CEO

Jonathan P. Mow

Exchange

NASDAQ

Website

http://www.phasebio.com

$2.00M

Total Revenue

40

Employees

$133.40M

Market Capitalization

-2.79

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$M

Net Margin (in %)

Total net margin

$M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 375797.27 82729.00 6.04 21.90 20.75
Merck & Co., Inc. MRK 200455.93 48081.00 7.53 19.78 21.10
Pfizer Inc. PFE 190327.35 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 149909.40 23087.00 50.87 26.42 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110955.81 31006.00 2.69 94.33 3.08
Repligen Corp. RGEN 6333.69 286.00 6.07 275.98 8.11
Reata Pharmaceuticals, Inc. RETA 4836.62 20.00 22.91 -15.56 -150.30
Nektar Therapeutics NKTR 4127.20 137.00 3.22 -8.98 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3604.64 1.00 33.33 -5.51 None
Allakos, Inc. ALLK 3162.63 None 6.87 -33.81 None
Karuna Therapeutics, Inc. KRTX 2767.96 None 7.23 -68.24 None
ADC Therapeutics SA ADCT 2741.31 2.00 32.33 -23.50 None
Turning Point Therapeutics, Inc. TPTX 2310.84 None 6.95 -19.33 None
IGM Biosciences, Inc. IGMS 2230.14 None 9.83 -41.11 None
Apellis Pharmaceuticals, Inc. APLS 2155.56 None 9.52 -5.17 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
OPKO Health, Inc. OPK 2088.87 891.00 1.48 -7.15 -32.92
Springworks Therapeutics, Inc. SWTX 1779.34 None 5.78 -28.54 None
Principia Biopharma, Inc. PRNB 1623.44 30.00 5.78 -23.10 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1556.96 None 9.54 -16.90 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Kiniksa Pharmaceuticals Ltd. KNSA 1401.40 None 7.26 -11.58 None
Akcea Therapeutics, Inc. AKCA 1348.30 341.00 2.77 -47.93 -8.59
Tricida, Inc. TCDA 1312.71 None 6.75 -6.22 None
Odonate Therapeutics, Inc. ODT 1232.79 None 10.10 -10.96 None
Arcutis Biotherapeutics, Inc. ARQT 1221.37 None 5.21 -19.53 None
Athenex, Inc. ATNX 1074.06 123.00 6.59 -9.98 -87.86
Phibro Animal Health Corp. PAHC 1066.00 818.00 5.38 28.89 4.49
Akero Therapeutics, Inc. AKRO 967.73 None 8.08 -19.07 None
Oric Pharmaceuticals, Inc. ORIC 957.32 None -10.39 -31.66 None
Constellation Pharmaceuticals, Inc. CNST 906.56 None 3.77 -9.77 None
G1 Therapeutics, Inc. GTHX 902.50 1.00 3.91 -6.88 None
Aprea Therapeutics, Inc. APRE 816.06 None 7.22 -24.14 None
Applied Therapeutics, Inc. APLT 795.30 None 5.13 -16.14 None
Gossamer Bio, Inc. GOSS 793.00 None 3.22 -3.99 None
Phathom Pharmaceuticals, Inc. PHAT 783.75 None 4.35 -2.88 None
Krystal Biotech, Inc. KRYS 773.16 None 4.51 -37.28 None
Quanterix Corp. QTRX 750.60 60.00 6.62 -17.16 -71.52
Keros Therapeutics, Inc. KROS 675.18 8.00 -30.50 -31.79 -285.35
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 635.68 1679.00 4.38 -2.92 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 627.25 19.00 58.13 -22.55 -151.34
Oyster Point Pharma, Inc. OYST 611.52 None 6.14 -10.63 None
Mirum Pharmaceuticals, Inc. MIRM 497.00 None 3.23 -7.34 None
SIGA Technologies, Inc. SIGA 492.00 19.00 5.50 -25.00 -94.00
Satsuma Pharmaceuticals, Inc. STSA 488.92 None 4.81 -13.44 None
Imara, Inc. IMRA 469.71 None 4.54 -13.35 None
Biospecifics Technologies Corp. BSTC 443.10 40.00 3.60 18.95 61.80
Crinetics Pharmaceuticals, Inc. CRNX 423.84 1.00 5.35 -7.27 -447.78
DURECT Corp. DRRX 418.50 28.00 32.14 -17.31 -82.94
Relmada Therapeutics, Inc. RLMD 402.75 0.00 6.01 -33.65 -877.66
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
Fulcrum Therapeutics, Inc. FULC 392.61 1.00 6.62 -5.69 None
Kala Pharmaceuticals, Inc. KALA 383.40 6.00 4.19 -4.18 None
TCR2 Therapeutics, Inc. TCRR 381.12 None 2.61 -37.81 None
Osmotica Pharmaceuticals Plc OSMT 363.42 232.00 2.76 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 328.95 None 7.78 -5.04 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 307.89 4.00 9.72 -3.84 -523.27
89bio, Inc. ETNB 297.09 None 3.67 -4.60 None
HOOKIPA Pharma, Inc. HOOK 291.72 13.00 2.64 -6.45 -333.02
IDEAYA Biosciences, Inc. IDYA 284.20 None 4.32 -6.52 None
AMAG Pharmaceuticals, Inc. AMAG 280.33 321.00 1.07 -0.76 -115.05
Lannett Co., Inc. LCI 268.66 542.00 0.92 -8.84 -5.77
Verrica Pharmaceuticals, Inc. VRCA 254.00 None 4.64 -8.33 None
Spero Therapeutics, Inc. SPRO 251.75 12.00 3.31 -3.10 -656.72
Gritstone Oncology, Inc. GRTS 235.80 4.00 2.11 -2.26 None
Kaleido Biosciences, Inc. KLDO 228.00 None 8.09 -3.11 None
KalVista Pharmaceuticals, Inc. KALV 218.16 12.00 2.41 -6.73 -263.38
Veru, Inc. VERU 218.08 39.00 7.29 -22.37 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Liquidia Technologies, Inc. LQDA 182.16 8.00 10.75 -3.70 -602.17
Galera Therapeutics, Inc. GRTX 180.50 None 3.37 -2.75 None
Sutro Biopharma, Inc. STRO 174.22 41.00 3.31 -2.86 -148.06
Protara Therapeutics, Inc. TARA 169.20 None 2.55 -10.97 None
Avenue Therapeutics, Inc. ATXI 168.00 532.00 30.88 -11.54 26.69
Evolus, Inc. EOLS 162.00 45.00 2.90 -1.60 -217.51
Evelo Biosciences, Inc. EVLO 159.36 None 4.08 -1.82 None
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 152.95 None 8.87 -7.00 None
scPharmaceuticals, Inc. SCPH 140.50 119.00 3.59 -4.48 -27.05
Lyra Therapeutics, Inc. LYRA 135.12 1.00 -1.15 -8.10 -491.16
Harrow Health, Inc. HROW 134.68 51.00 8.63 -5.45 -47.54
PhaseBio Pharmaceuticals, Inc. PHAS 133.40 2.00 2.47 -2.79 None
Aquestive Therapeutics, Inc. AQST 132.72 49.00 -7.65 -1.89 -139.64
Trevi Therapeutics, Inc. TRVI 125.82 None 2.67 -4.29 None
Mustang Bio, Inc. MBIO 125.80 None 2.94 -2.56 None
NeuBase Therapeutics, Inc. NBSE 122.92 None 51.65 -2.75 None
Ayala Pharmaceuticals, Inc. AYLA 120.00 3.00 -2.82 -5.81 -679.19
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
TFF Pharmaceuticals, Inc. TFFP 109.44 None 4.24 -2.82 None
Eton Pharmaceuticals, Inc. ETON 103.14 1.00 11.24 -5.16 None
Milestone Pharmaceuticals, Inc. MIST 94.25 None 0.93 -1.51 None
Clearside Biomedical, Inc. CLSD 82.00 6.00 10.53 -4.65 -293.61
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Corvus Pharmaceuticals, Inc. CRVS 78.01 None 1.25 -1.65 None
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Xeris Pharmaceuticals, Inc. XERS 76.44 4.00 3.79 -0.59 None
Baudax Bio, Inc. BXRX 73.98 None -2.01 -1.05 None
Navidea Biopharmaceuticals, Inc. NAVB 69.19 1.00 -50.88 -6.26 -65.13
BiomX, Inc. PHGE 67.43 None 1.78 -1.57 None
Genprex, Inc. GNPX 59.66 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 59.40 192.00 1.03 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 59.31 1.00 -24.41 -2.03 -851.00
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Eyenovia, Inc. EYEN 45.28 None 4.56 -2.21 None
Moleculin Biotech, Inc. MBRX 44.35 None 3.86 -4.82 None
Edesa Biotech, Inc. EDSA 44.10 0.00 6.28 -0.46 -395.23
Allena Pharmaceuticals, Inc. ALNA 36.34 None 4.79 -0.84 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.10 3.00 4.50 -1.39 -225.89
Mannatech, Inc. MTEX 33.83 156.00 1.43 7.62 3.45
CNS Pharmaceuticals, Inc. CNSP 33.44 None 5.81 -6.15 None
AgeX Therapeutics, Inc. AGE 32.90 2.00 -43.29 -2.71 -658.11
Acer Therapeutics, Inc. ACER 32.00 3.00 2.34 -1.23 -274.69
Aileron Therapeutics, Inc. ALRN 31.64 None 4.35 -1.19 None
Adamis Pharmaceuticals Corp. ADMP 31.30 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.52 None 2.79 -24.22 None
Citius Pharmaceuticals, Inc. CTXR 29.70 None 2.20 -1.72 None
Millendo Therapeutics, Inc. MLND 27.15 0.00 0.64 -0.58 None
Hoth Therapeutics, Inc. HOTH 25.30 None 7.03 -2.81 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.52 0.00 0.89 -0.90 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.96 1.00 8.31 -1.13 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Adial Pharmaceuticals, Inc. ADIL 14.20 None 3.46 -1.87 None
PDS Biotechnology Corp. PDSB 14.07 None 1.56 -0.55 None
Novan, Inc. NOVN 14.01 5.00 -3.22 -0.44 -602.34
Titan Pharmaceuticals, Inc. TTNP 11.80 4.00 4.92 -0.66 -437.91
Novus Therapeutics, Inc. NVUS 7.30 None 0.62 -0.35 None
Brickell Biotech, Inc. BBI 5.00 5.00 1.64 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Are Selling PhaseBio Pharmaceuticals, Inc. (PHAS)

16d ago, source: YAHOO!

In this article we will take a look at whether hedge funds think PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) is a good ...

PhaseBio Pharmaceuticals Inc.

8d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

PHAS PhaseBio Pharmaceuticals, Inc. Common Stock

27d ago, source: Nasdaq

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Analyst Opinions for PhaseBio Pharmaceuticals Inc Registered Shs

28d ago, source: Business Insider

2020 Insider Inc. and finanzen.net GmbH All rights ... Summary Recommendation Trends Price Target Summary for PhaseBio Pharmaceuticals 04/06/20 Citigroup Corp. GO IN-DEPTH ...

PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals® for PB2452

25d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

PhaseBio Pharmaceuticals – PB1046

1mon ago, source: GEN

The VIP analogue is a recombinant fusion protein composed of VIP and PhaseBio’s proprietary elastin-like polypeptide (ELP) biopolymer. Status: PhaseBio on May 27 said it will assess PB1046 as a ...

PhaseBio Pharmaceuticals Inc.

21d ago, source: MarketWatch

02/14/2020 N/A SC 13G/A Institutional Ownership * 01/27/2020 N/A SC 13G/A Institutional Ownership * 01/17/2020 N/A SC 13G/A Institutional Ownership * 04/22/2019 N/A SC 13G Institutional Ownership ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.